Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides anaesthesia, and patient monitoring and diagnostics products. The company offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Stock data | 2023 | Change |
---|---|---|
Price | $18.82 | N/A |
Market Cap | $4.90B | N/A |
Shares Outstanding | 260.48M | 2.56% |
Employees | 4.62K | N/A |
Shareholder Equity | 5.39B | 26.57% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 29.41 | N/A |
P/S Ratio | 7.40 | N/A |
P/B Ratio | 0.91 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0043 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $662.38M | N/A |
Earnings | $23.30M | N/A |
EPS | 0.64 | N/A |
Earnings Yield | 0.034 | N/A |
Gross Margin | 0.5682 | N/A |
Operating Margin | 0.0632 | N/A |
Net income margin | 0.0352 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $951.46M | N/A |
Total Debt | $81.01M | N/A |
Cash on Hand | $21.78M | N/A |
Debt to Equity | 0.0377 | -60.79% |
Cash to Debt | 0.2688 | 165.24% |
Current Ratio | $2.13 | 7.41% |